Risk for Dementia Reduced in Association With Antihypertensive Use
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Sept. 13, 2023 -- Antihypertensive use is associated with a reduced risk for dementia compared with untreated hypertension, according to research published online Sept. 12 in JAMA Network Open.
Matthew J. Lennon, M.D., from the University of New South Wales in Sydney, and colleagues examined the associations of hypertension history, antihypertension use, and baseline-measured blood pressure (BP) in late life with dementia in longitudinal, population-based studies of aging adults participating in the Cohort Studies of Memory in an International Consortium group. The analysis included 17 studies with 34,519 community-dwelling older adults (mean age, 72.5 years) and a mean follow-up of 4.3 years.
The researchers found that individuals with untreated hypertension had a significantly increased risk for dementia compared with healthy controls and with individuals with treated hypertension in the main, partially adjusted analysis including 14 studies (hazard ratios, 1.42 and 1.26, respectively). The risk for dementia was not increased significantly for those with treated hypertension versus healthy controls. There was no variation observed in the association of antihypertensive use or hypertension status with dementia according to baseline BP.
"Antihypertensive use was associated with decreased dementia risk in late-life individuals with hypertension; thus, dementia risk reduction may be one of the multiple goals of antihypertensive treatment in late-life (e.g., prevention of ischemic heart disease, chronic kidney disease)," the authors write.
Several authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
Intensive HTN Treatment Cuts Early T2D Diagnosis-Linked CVD Event Risk
MONDAY, April 29, 2024 -- More intensive hypertensive therapy significantly reduces the excess risk for cardiovascular disease (CVD) events associated with earlier hypertension...
Warning Letters Can Reduce Quetiapine Overprescribing
MONDAY, April 29, 2024 -- For patients with dementia, letters warning primary care physicians (PCPs) regarding overprescribing can reduce quetiapine prescriptions, according to a...
Nursing Home Staff Shortages Tied to More Inappropriate Antipsychotic Use
FRIDAY, April 26, 2024 -- Nursing homes with staffing shortages have higher inappropriate antipsychotic medication use, particularly among nursing homes in severely deprived...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.